Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
5.99
-0.15 (-2.44%)
May 2, 2025, 4:00 PM EDT - Market closed
Exagen Market Cap
Exagen has a market cap or net worth of $107.75 million as of May 2, 2025. Its market cap has increased by 346.52% in one year.
Market Cap
107.75M
Enterprise Value
109.07M
1-Year Change
346.52%
Ranking
Category
Stock Price
$5.99
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $107.75M, an increase of 70.74%. That is a compound annual growth rate of 9.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 739.39B |
Johnson & Johnson | 375.64B |
UnitedHealth Group | 364.02B |
AbbVie | 351.09B |
Novo Nordisk | 307.48B |
Abbott Laboratories | 231.09B |
Novartis AG | 223.50B |
AstraZeneca | 221.69B |